Including Oxybenzone, Octinoxate On US Sunscreen Monograph Could Swing On Environmental Impact

FDA will prepare an environmental impact statement on sunscreen ingredients oxybenzone and octinoxate in light of questions on the ingredients’ impact on coral and coral reefs. It plans to complete the review prior to publishing final order for its OTC sunscreen ingredients monograph.

Sunscreen coral reef

The US Food and Drug Administration adds environmental impact questions to its consideration of whether oxybenzone and octinoxate will remain available as OTC sunscreen monograph ingredients.

The agency on 12 May published a notice stating that an environmental impact statement (EIS) it is required to prepare for oxybenzone and octinoxate could lead to either or both of the ingredients remaining eligible for inclusion in its OTC sunscreen

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation